WallStreetZenWallStreetZen

NASDAQ: APM
Aptorum Group Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their APM stock forecasts and price targets.

Forecast return on equity

Is APM forecast to generate an efficient return?

Company
1,840.16%
Industry
19.5%
Market
295.17%
APM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is APM forecast to generate an efficient return on assets?

Company
2,351.32%
Industry
13.5%
APM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

APM earnings per share forecast

What is APM's earnings per share in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
$59.59

APM revenue forecast

What is APM's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$146.8M

APM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APM$1.47N/AN/A
CLRB$3.26N/AN/A
NEUP$4.40$28.00+536.36%Strong Buy
EVGN$1.23$3.50+184.55%Strong Buy
BOLT$5.73$35.67+522.35%Buy
View Top Biotech Stocks

Aptorum Group Stock Forecast FAQ

What is APM's earnings growth forecast for 2025-2025?

(NASDAQ: APM) Aptorum Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Aptorum Group's earnings in 2025 is -$2,065,790.

In 2025, APM is forecast to generate $425,696,480 in earnings, with the lowest earnings forecast at $413,052,030 and the highest earnings forecast at $442,555,746.

If you're new to stock investing, here's how to buy Aptorum Group stock.

What is APM's revenue growth forecast for 2025-2025?

(NASDAQ: APM) Aptorum Group's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Aptorum Group's revenue in 2025 is $0.

In 2025, APM is forecast to generate $1,048,703,528 in revenue, with the lowest revenue forecast at $459,957,938 and the highest revenue forecast at $1,687,712,591.

What is APM's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: APM) forecast ROA is 2,351.32%, which is higher than the forecast US Biotechnology industry average of 13.5%.

What is APM's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: APM) Aptorum Group's current Earnings Per Share (EPS) is -$0.34. In 2025, APM's EPS is forecast to hit $59.59 (min: $57.82, max: $61.95).

What is APM's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: APM) forecast ROE is 1,840.16%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.